• Nektar, Pfizer Announce Oncology Clinical Collaboration americanpharmaceuticalreview
    November 10, 2018
    Nektar Therapeutics has entered into an oncology clinical collaboration with Pfizer to evaluate several combination regimens in multiple cancer settings, including metastatic castration-resistant prostate cancer (mCRPC) and squamous cell carcinoma of the
  • Nektar, Pfizer Announce Oncology Clinical Collaboration americanpharmaceuticalreview
    November 10, 2018
    Nektar Therapeutics has entered into an oncology clinical collaboration with Pfizer to evaluate several combination regimens in multiple cancer settings, including metastatic castration-resistant prostate cancer (mCRPC) and squamous cell carcinoma of the
  • Could Nektar Therapeutics Be Worth More? fool
    March 24, 2017
    Nektar Therapeutics is an intriguing commercial-stage biotech company that's just reported positive late-stage trial results for its pain-busting drug NKTR-181. However, shares have jumped on the news, and the company's market cap has swollen to more than
PharmaSources Customer Service